We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:RPRX
​
​
logo

Royalty Pharma (RPRX)

Nasdaq • RPRX • GB00BMVP7Y09

Ex-dividend 13 Nov · 0.235 USD (special)
66.40Last close
Market Closed
Ex-dividend 13 Nov · 0.235 USD (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 3.1% of free float is sold short, 3.9 days to cover, cost to borrow 0.4%.

Market Cap

29.6b USD | # 726 in US

Volume

3.08m shares | 185.41m USD

Shares Outstanding

445.28m

Free Float Shares

93.78% | 417.57m

DB:RPD

News

RPRX key data

Royalty Pharma (Nasdaq: RPRX) has a market capitalization of $29.57B. Last close $66.40 (as of 2026-11-04); 52-week range $36.03 to $67.71. ORTEX data as of 2026-11-03: short interest is 3.05% of free float, 3.9 days to cover and the average cost to borrow is 0.4%.

  • RPRX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.